Literature DB >> 20921411

Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes.

Sergio L Colombo1, Miriam Palacios-Callender, Nanci Frakich, Joel De Leon, Christoph A Schmitt, Leanne Boorn, Nicola Davis, Salvador Moncada.   

Abstract

Cell proliferation is accompanied by an increase in the utilization of glucose and glutamine. The proliferative response is dependent on a decrease in the activity of the ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C)-Cdh1 which controls G1-to-S-phase transition by targeting degradation motifs, notably the KEN box. This occurs not only in cell cycle proteins but also in the glycolysis-promoting enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 (PFKFB3), as we have recently demonstrated in cells in culture. We now show that APC/C-Cdh1 controls the proliferative response of human T lymphocytes. Moreover, we have found that glutaminase 1 is a substrate for this ubiquitin ligase and appears at the same time as PFKFB3 in proliferating T lymphocytes. Glutaminase 1 is the first enzyme in glutaminolysis, which converts glutamine to lactate, yielding intermediates for cell proliferation. Thus APC/C-Cdh1 is responsible for the provision not only of glucose but also of glutamine and, as such, accounts for the critical step that links the cell cycle with the metabolic substrates essential for its progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921411      PMCID: PMC2973876          DOI: 10.1073/pnas.1012362107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.

Authors:  C M Pfleger; M W Kirschner
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 2.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

3.  The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.

Authors:  Angel Herrero-Mendez; Angeles Almeida; Emilio Fernández; Carolina Maestre; Salvador Moncada; Juan P Bolaños
Journal:  Nat Cell Biol       Date:  2009-05-17       Impact factor: 28.824

Review 4.  Bioenergetics of tumor cells: glutamine metabolism in tumor cell mitochondria.

Authors:  T Matsuno
Journal:  Int J Biochem       Date:  1987

5.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

6.  E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation.

Authors:  Angeles Almeida; Juan P Bolaños; Salvador Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 7.  Tumor suppressors and cell metabolism: a recipe for cancer growth.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

Review 8.  Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance.

Authors:  E A Newsholme; B Crabtree; M S Ardawi
Journal:  Q J Exp Physiol       Date:  1985-10

9.  Regulation of leucine-stimulated insulin secretion and glutamine metabolism in isolated rat islets.

Authors:  Changhong Li; Habiba Najafi; Yevgeny Daikhin; Ilana B Nissim; Heather W Collins; Marc Yudkoff; Franz M Matschinsky; Charles A Stanley
Journal:  J Biol Chem       Date:  2002-11-19       Impact factor: 5.157

10.  The function of APC/CCdh1 in cell cycle and beyond.

Authors:  Min Li; Pumin Zhang
Journal:  Cell Div       Date:  2009-01-19       Impact factor: 5.130

View more
  58 in total

1.  Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

Authors:  Isabel Garcia-Cao; Min Sup Song; Robin M Hobbs; Gaelle Laurent; Carlotta Giorgi; Vincent C J de Boer; Dimitrios Anastasiou; Keisuke Ito; Atsuo T Sasaki; Lucia Rameh; Arkaitz Carracedo; Matthew G Vander Heiden; Lewis C Cantley; Paolo Pinton; Marcia C Haigis; Pier Paolo Pandolfi
Journal:  Cell       Date:  2012-03-06       Impact factor: 41.582

2.  Linking metabolism and cell cycle progression via the APC/CCdh1 and SCFβTrCP ubiquitin ligases.

Authors:  Shanshan Duan; Michele Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

Review 3.  Structural insights into anaphase-promoting complex function and mechanism.

Authors:  David Barford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

4.  Nonparametric Bayesian evaluation of differential protein quantification.

Authors:  Oliver Serang; A Ertugrul Cansizoglu; Lukas Käll; Hanno Steen; Judith A Steen
Journal:  J Proteome Res       Date:  2013-09-11       Impact factor: 4.466

5.  Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.

Authors:  K Thangavelu; Catherine Qiurong Pan; Tobias Karlberg; Ganapathy Balaji; Mahesh Uttamchandani; Valiyaveettil Suresh; Herwig Schüler; Boon Chuan Low; J Sivaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-26       Impact factor: 11.205

6.  A fresh look at cancer metabolism in a historical setting.

Authors:  Almut Schulze
Journal:  EMBO Rep       Date:  2011-03-18       Impact factor: 8.807

Review 7.  Two-way communication between the metabolic and cell cycle machineries: the molecular basis.

Authors:  Joanna Kaplon; Loes van Dam; Daniel Peeper
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.

Authors:  Zhiguo Li; Jie Li; Pengpeng Bi; Ying Lu; Grant Burcham; Bennett D Elzey; Timothy Ratliff; Stephen F Konieczny; Nihal Ahmad; Shihuan Kuang; Xiaoqi Liu
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

Review 9.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 10.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.